Bristol-Myers Squibb Company (BMY) · page 197 of 197
The slide uses a clear 'us vs. them' framing, positioning the proposed acquisition as high-risk and value-destructive compared to the standalone alternative.
Activist deck · closing_ask · closing_ask · dense density
Slide locked Sign in to view
Slide schematic 5/6
callout 1/1 list 1/1 metric 0/1 paragraph 1/1 source-note 1/1 title 1/1
1 without position metric 1
metric · primary
Components 6
primary bullet primary paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1